Arvinas (ARVN) Net Cash Flow Growth (5y) (2022 - 2026)
Arvinas (ARVN) Net Cash Flow Growth (5y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,583.17 Bn | 67,582.89 Bn | - |
| 2 | Nanobiotix | 1,947.22 Bn | 1,947.15 Bn | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - |
| 4 | BeOne Medicines | 473.21 Bn | 468.42 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 123.29 Bn | 116.04 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.05 Bn | 61.29 Bn | 3.31 Bn |
| 7 | Belite Bio | 63.09 Bn | 63.09 Bn | - |
| 8 | Argenx Se | 56.63 Bn | 51.45 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.79 Bn | 37.79 Bn | - |
| 10 | Arvinas | 532.48 Mn | -82.42 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 25.50% |
| Dec 31, 2025 | -39.23% |
| Sep 30, 2025 | -17.07% |
| Jun 30, 2025 | 34.10% |
| Mar 31, 2025 | -22.20% |
| Dec 31, 2024 | 48.39% |
| Sep 30, 2024 | -149.49% |
| Jun 30, 2024 | 42.27% |
| Mar 31, 2024 | -60.77% |
| Dec 31, 2023 | 132.53% |
| Sep 30, 2023 | 52.09% |
| Jun 30, 2023 | 7.18% |
| Mar 31, 2023 | 10.32% |
| Dec 31, 2022 | -30.62% |